Moderna, Inc. (FRA:0QF)
23.21
-0.30 (-1.26%)
Jun 13, 2025, 8:23 AM CET
Moderna Revenue
Moderna had revenue of $108.00M USD in the quarter ending March 31, 2025, a decrease of -35.33%. This brings the company's revenue in the last twelve months to $3.18B, down -38.35% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.18B
Revenue Growth
-38.35%
P/S Ratio
3.18
Revenue / Employee
$547.76K
Employees
5,800
Market Cap
9.35B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.14B |
Merck KGaA | 21.32B |
Bayer Aktiengesellschaft | 46.58B |
Fresenius SE & Co. KGaA | 22.13B |
Fresenius Medical Care AG | 19.49B |
Sartorius Aktiengesellschaft | 3.44B |
Carl Zeiss Meditec AG | 2.17B |
Fielmann Group AG | 2.33B |
Moderna News
- 12 days ago - Moderna wins FDA nod for next-gen COVID-19 shot - Seeking Alpha
- 12 days ago - US approves new Moderna Covid jab for over-65s - Bangkok Post
- 13 days ago - New Covid vaccine approved by US FDA: Here's all about it - The Times of India
- 13 days ago - US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older - Reuters
- 13 days ago - Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE - Wallstreet:Online
- 13 days ago - Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE - Accesswire
- 14 days ago - Trump Administration Cancels $600 Million Contract to Develop Bird Flu Vaccine - Yahoo
- 14 days ago - Moderna, Inc. (MRNA) Bernstein 41st Annual Strategic Decisions Conference Call Transcript - Seeking Alpha